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Abstract: We report the results of serological survey of hepatitis C virus (HCV) and
hepatitis B virus (HBV) infections among the human immunodeficiency virus (HIV)
seropositive and seronegative blood donors in Chiang Mai, Thailand, Anti-HCV were
positive in 17 out of 276 anti-HIV seropositive blood donors (6.2%) and six out of 844
anti-HIV seronegative blood donors (0.7%). HBs-Ag were positive in 20 out of 276
anti-HIV seropositive blood donors (7.2%) and 68 out of 844 anti-HIV seronegative blood
donors (8.1%). These findings suggest that anti-HIV seropositive population belongs to a
high risk group of HCV infection and there are similar transmission routes between HIV
and HCV infections.
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INTRODUCTION
viral hepatitis is one of the most common and serious consequences of blood-borne virus
infections (Alter et.al., 1972; Alter et al., 1975; Stevens et al., 1984). Since the introduction of
routine donor blood screening for hepatitis B surface antigen (HBs-Ag), the incidence of HBV
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i nfection has decreasesd and non-A, non-Bhepatitis has become the major cause of posttran-
sfusional hepatitis (Stevens et al., 1984). Although the genome of blood-borne non-A, non-B
agent, designated as hepatitis C virus (HCV), has been cloned and specific assays for HCV in-
fection have been developed (Choo et al., 1989), there are still many sporadic cases of HCV in-
fection without history of blood transfusions. Several authors reported that there are high risk
groups of HCV and HBV infections which relate to human immunodeficiency virus (HIV) infec-
tion (Esteban et al., 1989; Sherman et al., 1991; Quan et al., 1993; Eysler et al., 1993; Botti et al.,
1992; Bryan et al., 1993). The number of anti-HIV positive populations has increased in Northern
Thailand (Nelson et al., 1993). However, no seroepidemilogical survey of the HCV and HBV in-
fections has been done among the blood donor populations in this area. It is the purpose of this
study to know the prevalences of HCV and HBV infections among the anti -HIV seropositive and
seronegative populations and discuss the transmission routes of these blood-borne diseases in
Northern Thailand.
MATERIALS AND METHODS
The sera from 276 anti-HIV seropositive blood donors (male: 254, female: 22) and 844
anti-HIV seronegative blood donors (male: 698, female: 146) in the blood bank of Maharaj
Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, were collected and stored at- 20 °C between
January and November, 1991. Sera were tested for anti-HIV by using EIA kit (Abbott 3rd
generation anti-HIV EIA, Abbott Lab. Ltd., North Chicago, IL, USA). The positive sera were
confirmed by using indirect ELISA (Anti-HIV, 1/2 Behring, Germany) and Gel Particle Ag-
gulutination method (GPA-anti-HIV, Kyowa Hakko, Japan). The anti- HCV was assayed in all
blood donors by a second generation EIA kit (Hepanostika C, Organon Teknika B. V. Boxtel,
Holland). The HBs-Ag was tested by Reverse Hemagglutination method (Thai Red Cross,
Bangkok, Tailand).
The statistical analysis of the results was performed using chi-square test (P< 0.0001).
RESULTS
Table 1 shows the prevalence of HCV infection among the anti-HIV seropositive and
seronegative blood donors. Seventeen out of 276 anti -HIV seropositive donors (6.2%) and six out
of 844 anti-HIV seronegative donors (0.7%) showed anti-HCV positive (P< 0.0001). Among the
anti- HIV seropositive donors, male showed slightly high incidence of HCV infection (6.3%) than
female (4.5%). Among the anti-HIV seronegative donors, male showed 0.9% of anti-HCV
positive and female showed 0.0%.
Table 2 describes the prevalence of HBs-Ag positive among the anti-HIV seropositive
and seronegative blood donors. Twenty out of 276 anti-HIV seropositive donors (7.2%) and
68 out of 844 anti- HIV seronegative donors (8. 1%) were HBs -Ag positive. Male showed slightly
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Table 1 Prevalence of HCV infection among
anti-HIV seropositive and seronega-
tive blood donors
No. tested Anti-HCV positive














T able 2 Prevalence of HBV infection among
anti-HIV seropositive and seronega-
tiVe blood donors
No. tested HBs-Ag positive
A nti -HIV positive
Male 254 19 (7. 5%)
Female 22 1 (4. 5%)
Total 276 20 (7. 2%)
Anti - HIV negative
Male 698 64 (9. 2%)
Female 146 4 (2. 7%)
total 844 68 (8. 1%)
higher incidence (7.5%) than female (4.5%) among the anti-HIV seropositive donors. Male
showed higher incidence (9.2%) of HBs-Ag positive than female (2.7%) among the anti-HIV
seronegative donors.
DISCUSSION
Several authors reported that there are high risk groups of HCV and HBV infections among
HIV infected populations (Van der Doel et al., 1989; Esteban et. al., 1989; Sherman et al., 1991;
Stary et al., 1992; Quan et al., 1993; Eysler et al., 1993; Bryan et al., 1993). Although the number
of HIV infected populations has increased in Northern Thailand (Nelson et al., 1993), no
seroepidemiological survey on HCV and HBV infections has been done among the anti-HIV
seropositive populations.
In our study, six out of 844 anti-HIV seronegative blood donor (0.7%) were found to be
positive for anti - HCV,which predicts the average incidence of HCV infection among the healthy
populations in Northern Thailand. The incidence of 0.7% is relatively low in comparison to the
ones of surrounding countries; 3.1% of blood donors in Indonesia (Amirudin et al., 1991), 2.2% of
such individuals in the Philippines (Arguillas et al., 1991) and 6.5% of healthy populations in
Cambodia (Thuring et al., 1993).
The incidence of anti-HCV positivity among the anti-HIV seropositive donors was 6.2
% in the present study, which was almost nine times higher than the one of 0.7% among HIV
seronegative donors. This rate is almost similar to those of the previous reports (Sherman et al.,
1991; Botti et al., 1992; Eysler et al., 1993; Bryan et al., 1993). These findings suggest that anti
-HIV seropositive donors belong to a high risk group of HCV infection. In our results, the high
prevalences of anti- HCV and anti-HIV positivities were found amongthe young age group of
male, 20 - 29 years old, who were active for sexual behaviors. Nelson et al. (1993) reported that the
young group belongs to a high risk group of HIV infection through intravenous drug abuse and
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prostitute contacts in Northern Thailand. Also several reports described the possibility of heter-
osexual transmission of HCV infection (Alter et al., 1989, Esteban, 1993). Our findings suggest
that one.of the transmission routes of HCV infection takes a similar way of HIV infection in this
area.
It is well known that HBV infections are very commonamongthe AIDS patients, especially
amonghomosexuals (Botti et al., 1992). However, the prevalence of HBs-Ag positivity in our
study was not significantly different between HIV seropositive and seronegative blood donors,
7.2% and 8.1%, respectively. Our finding is not easy to intepret. One of the reasons of this result
might be that many of the HIV seropositive individuals in our study were not suffering from
immunocompromized stage yet.
In conclusion, the high prevalence of HCV infection was found among the anti-HIV
seropositive blood donors in Northern Thailand. This finding suggest that the both blood borne
virus infections might share similar routes of transmission.
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